Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancerLargest real-world, ...

Trends in Lung Cancer Incidence and Mortality (1990-2019) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities A total of 7,413 tumor specimens were tested. The ...

An expert discusses the evolution of ROS1 testing in non-small cell lung cancer, highlighting the shift from FISH-based methods to comprehensive next-generation sequencing of both tissue and plasma, ...

The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma We conducted a real-world cohort study ...

Happiest Diagnostics, under Happiest Health, has secured NABL accreditation within two years of its inception, paving the way for growth in molecular, genomic, and preventive diagnostics. This ...

Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

FREDERICTON, New Brunswick--(BUSINESS WIRE)--LuminUltra (luminultra.com), the global leader in applied molecular diagnostics, today announced the acquisition of the legionella testing business assets ...

ST. PAUL, Minn. and VANCOUVER, Wash., Dec. 18, 2023 /PRNewswire/ -- Intending to reshape the landscape of at-home medical diagnostic testing, GRIP Molecular Technologies (GRIP) and Molecular Testing ...

Syndromic infectious disease testing is designed to simultaneously identify multiple pathogens responsible for similar clinical symptoms in a single test. Traditional testing methods typically only ...